Contact Us Opus Genetics Opus Genetics
Opus Genetics is a patient-first, science driven gene therapy company tackling manufacturing obstacles standing in the way of treatments for ultra-rare blinding conditions.
WE COLLABORATE
WE COLLABORATE
With patient organizations, clinicians, and other stakeholders to ensure a patient-first priority.
WE DEVELOP
WE DEVELOP
AAV-based gene therapies to treat ultra-rare retinal degenerative diseases.
WE BUILD
WE BUILD
Capabilities to tackle manufacturing obstacles and access treatments.

Startup Team

Ben Yerxa, PhD
Ben Yerxa, PhD
Co-Founder & President
Opus Genetics
Rusty  Kelley, PhD, MBA
Rusty Kelley, PhD, MBA
Co-Founder & Board Director
Opus Genetics
Jean Bennett, MD, PhD
Jean Bennett, MD, PhD
Co-Founder & Board Director
Opus Genetics
Jason D. Menzo
Jason D. Menzo
Co-Founder
Opus Genetics
Peter Ginsberg, MBA
Peter Ginsberg, MBA
Co-Founder
Opus Genetics